1-5 of 5
Michael Dennis, MDMRCP,FRCPath
Close
Sort by
Journal Articles

The Achievement of Complete Remission Is Associated with Improved Quality of Life in Non-Intensively Treated Patients with Acute Myeloid Leukemia: Results of the UK NCRI LI-1 Tria

Robert K. Hills, MA,DPhil,MSc, Ian Thomas, Alan K. Burnett, MD, Claire Jane Hemmaway, MD, Helen Dignum, Nigel H. Russell, Michael Dennis, MDMRCP,FRCPath
Journal: Blood
Blood (2018) 132 (Supplement 1): 372.
https://doi.org/10.1182/blood-2018-99-116173
Published: 2018
Journal Articles

Children and Adults with Steroid-Refractory Acute Graft-Versus-Host Disease Respond to Treatment with the Mesenchymal Stroma Cell Preparation "MSC-FFM": Treatment Results for 92 Consecutive Patients

Peter Bader, MD PhD, Selim Kuci, Zyrafete Kuci, Shahrzad Bakhtiar, MD, Oliver Basu, Gesine Bug, Michael Dennis, MDMRCP,FRCPath, Johann Greil, MD, Aniko Barta, MD, Krisztián Kallay, MD, Peter Lang, MD, Giovanna Lucchini, MD, Raj Pol, Ansgar Schulz, MD, Karl-Walter Sykora, MD, Irene Teichert von Luettichau, MD, Grit Herter-Sprie, MD, Mohammad Ashab Uddin, Philip Jenkin, Abdulrahman Alsultan, Jochen Büchner, MDPhD, Jerry Stein, MD, Agnes Kelemen, MD, Andrea Jarisch, PhD MD, Jan Soerensen, MD, Emilia Salzmann-Manrique, Martin Hutter, Richard Schaefer, Erhard Seifried, MD, Shankara Paneesha, MD, Igor Novitzky-Basso, Aharon Gefen, Neta Nevo, MD, Gernot Beutel, MD, Paul G. Schlegel, MD, Thomas Klingebiel, MD, Halvard Bonig, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 603.
https://doi.org/10.1182/blood-2018-99-110599
Published: 2018
Journal Articles

An Evaluation of 17 Years of Low Dose Cytarabine As Therapy for AML Patients Not Fit for Intensive Treatment, Including Patients with Adverse Cytogenetics, Shows Improving Survival, Potential Underutilisation and Highlights the Need for New Therapy

Michael Dennis, MDMRCP,FRCPath, Robert K. Hills, DPhil, Nigel H. Russell, Mhairi Copland, PhD MBBChir, FRCP, FRCPath, Ian Thomas, Mary Frances Frances McMullin, MB,Bch BAO, MD FRCPath, Sahra Ali, Alan K. Burnett, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3874.
https://doi.org/10.1182/blood.V130.Suppl_1.3874.3874
Published: 2017
Journal Articles

Combined Azacitidine and High Dose Lenalidomide Therapy Is Well Tolerated and Clinically Active in Patients Who Relapse after Allogeneic Stem Cell Transplantation for Actue Myeloid Leukemia: Results of the Uk Trials Acceleration Programme Viola Trial

Charles Craddock, Wendy Ingram, Daniel Slade, Andrea Hodgkinson, BSc(Hons),PhD, Francis J. Mussai, MA, MD DPhil, Carmela De Santo, Jamie Cavenagh, Michael Dennis, MDMRCP,FRCPath, Ram Malladi, MRCP, FRCPath, PhD, Shamyla Siddique, BSc.(Hons.), MPhil, Yap Christina, MSci, PhD CStat
Journal: Blood
Blood (2017) 130 (Supplement 1): 276.
https://doi.org/10.1182/blood.V130.Suppl_1.276.276
Published: 2017
Journal Articles

Treatment of Patients with Therapy-Refractory Acute GvHD with the Novel MSC Product "MSC-Ffm" Resulted in Excellent Response and Low Mortality: Post-Approval Observational Data from 69 Consecutive Patients

Peter Bader, MD PhD, Selim Kuci, Zyrafete Kuci, Shahrzad Bakhtiar, MD, Oliver Basu, MD, Gesine Bug, MD, Michael Dennis, MDMRCP,FRCPath, Johann Greil, MD, Aniko Barta, MD, Krisztián Kallay, MD, Peter J. Lang, MD, Giovanna Lucchini, MD, Raj Pol, Ansgar S. Schulz, MD, Karl-Walter Sykora, MD, Irene Teichert von Luettichau, MD, Grit Herter-Sprie, MD, Mohammad Ashab Uddin, Philip Jenkin, Abdulrahman S. Alsultan, MD, Jochen Büchner, MDPhD, Jerry Stein, MD, Agnes Kelemen, MD, Shankaranarayana Paneesha, Andrea Jarisch, PhD MD, Jan Soerensen, MD, Emilia Salzmann-Manrique, Erhard Seifried, MD PhD, Thomas Klingebiel, MD, Halvard Bonig, MD MA
Journal: Blood
Blood (2017) 130 (Supplement 1): 514.
https://doi.org/10.1182/blood.V130.Suppl_1.514.514
Published: 2017